---
title: "华东医药的子公司获得了进口药品补充申请的批准"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/266299971.md"
description: "华东医药的子公司获得进口药品补充申请的批准"
datetime: "2025-11-18T04:20:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266299971.md)
  - [en](https://longbridge.com/en/news/266299971.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266299971.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/266299971.md) | [繁體中文](https://longbridge.com/zh-HK/news/266299971.md)


# 华东医药的子公司获得了进口药品补充申请的批准



### 相关股票

- [华东医药 (000963.CN)](https://longbridge.com/zh-CN/quote/000963.CN.md)

## 相关资讯与研究

- [华东医药：注射用 DR30206 临床试验申请获得批准](https://longbridge.com/zh-CN/news/277450215.md)
- [华东医药：DR10624 注射液临床试验申请获批准](https://longbridge.com/zh-CN/news/274790886.md)
- [凯发电气以简易程序向特定对象发行股票申请获得深交所受理](https://longbridge.com/zh-CN/news/277558967.md)
- [卫光生物：人凝血因子Ⅸ境内生产药品注册临床试验获批准](https://longbridge.com/zh-CN/news/278074375.md)
- [金三江发行可转债申请获深交所审核通过](https://longbridge.com/zh-CN/news/277917126.md)